ArticleFrontiers in oncology2022

Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma.

Qianhui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.